IRCT201202281556N36CompletedPhase 2
Saffron versus fluoxetine in the treatment of mild to moderate depression in post PCI patients: a double blind randomized clinical trial
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •Inclusion: 1. Patients underwent angioplasty 2. Have depression based on DSM-IV-TR and score of 14-22 on Hamilton Depression Rating Scale 3. Informed consent Exclusion : 1.Psychosis 2. Current use of other psychotropic agents 3.Antidepressant in the last month 4.ECT in the previous two months 5- Thyroid problem 6.Lactation and pregnancy 7. Problems in other DSM axes 8.History of substance abuse or dependence during the last three months 9. High risk of suicide 10. Oral contraception use 11. Women of child-bearing if willing to be pregnant 12.Need for unusual psychiatric treatment
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 2
Saffron versus Methylphenidate in the treatment of Attention Deficit Hyperactivity DisorderDisturbance of activity and attention.Disturbance of activity and attentionIRCT201701131556N94Tehran University of Medical Sciences40
Completed
Phase 3
Effect of Saffrons in Premenstrual SyndromePremenstual Syndrom.Unspecified condition associated with female genital organs and menstrual cycleIRCT2017061233202N2Vice chancellor for research, Sabzevar University of Medical Sciences164
Completed
Phase 3
Saffron in the treatment of post-partum depressioPost partum depression.Mental and behavioural disorders associated with the puerperium, not elsewhere classifiedIRCT201509201556N82Tehran University of Medical Sciences50
Not yet recruiting
Phase 3
Effect of saffron in treatment of depression in diabetes patientsIRCT20220309054235N1Ahvaz University of Medical Sciences60
Completed
Phase 3
Saffron Vs duloxetine in the treatment of FibromyalgiaFibromyalgia.FibromyalgiaIRCT201604261556N91Tehran University of Medical Sciences50